CAS: 152121-53-4 - PD 169316
4-(4-(4-Fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl)pyridine
CAS:152121-53-4
Formula:
C20H13FN4O2
Purity:
95%
Color and Shape:
Solid
Molecular weight:
360.3412
Ref: IN-DA003K1M
1g | To inquire | ||
10mg | 59.00 € | ||
25mg | 112.00 € | ||
50mg | 155.00 € | ||
100mg | 188.00 € | ||
250mg | 318.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
PD 169316
CAS:152121-53-4
Formula:
C20H13FN4O2
Purity:
>98.0%(HPLC)
Color and Shape:
Light yellow to Brown powder to crystal
Molecular weight:
360.35
Ref: 3B-P2532
10mg | 137.00 € | ||
50mg | 431.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
PD169316
CAS:152121-53-4
Formula:
C20H13FN4O2
Purity:
98.2% (Typical Value in Batch COA)
Color and Shape:
yellow solid
Molecular weight:
360.34g/mol
Ref: 54-BISN0170
1mg | 75.00 € | ||
5mg | 135.00 € | ||
10mg | 237.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
PD 169316
CAS:152121-53-4
PD 169316 is a potent, cell-permeable and selective p38 MAP kinase inhibitor.
Formula:
C20H13FN4O2
Purity:
98.65%
Color and Shape:
Solid
Molecular weight:
360.34
Ref: TM-T2432
5mg | 57.00 € | ||
10mg | 90.00 € | ||
25mg | 135.00 € | ||
50mg | 217.00 € | ||
100mg | 376.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
PD 169,316
CAS:152121-53-4
M02298 - PD 169,316
Formula:
C20H13FN4O2
Purity:
>98%
Color and Shape:
Solid
Molecular weight:
360.3479919433594
Ref: 10-M02298
25mg | To inquire |
Estimated delivery in United States, on Wednesday 18 Dec 2024
PD 169316
CAS:152121-53-4
Inhibitor of p38 kinase
Formula:
C20H13FN4O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
360.34 g/mol
Ref: 3D-FP99820
5mg | 136.00 € | ||
10mg | 184.00 € | ||
25mg | 345.00 € | ||
50mg | 539.00 € | ||
100mg | 986.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
PD-169316
Controlled ProductCAS:152121-53-4
Formula:
C20H13FN4O2
Color and Shape:
Neat
Molecular weight:
360.341
Ref: TR-P217600
250mg | 3,568.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025